• Ximena Valladares, Rafael Benavente, Christine Rojas, Camila Peña, Rodrigo Valenzuela, Virginia Monardes, Hernán López, Marcelo Abarca, Pilar León, Rocío Osorio, Erika Pérez, Pablo Soto, Gabriel La Rocca, Daniela Cardemil, Vivianne Torres, Marvila Intriago, María Elena Cabrera, and María Soledad Undurraga.
• Hospital del Salvador, Santiago, Chile.
• Rev Med Chil. 2021 Nov 1; 149 (11): 1532-1538.

BackgroundPhiladelphia-negative myeloproliferative neoplasms (Ph-MPN) are chronic hematological disorders characterized by the overproduction of one or more mature myeloid blood cell lineages. Classical Ph-MPN are polycythemia vera (PV), essential thrombocytopenia (ET) and primary myelofibrosis (PMF).AimTo assess the epidemiological, clinical and diagnostic characteristics of Ph-MPN in Chile.Material And MethodsRetrospective review of medical records of all patients referred as MPN from 2012 to 2017. Patients with (9;21) translocation were excluded.ResultsData of 462 cases with a median age of 69 years from 10 public hospitals was reviewed. ET was the most frequently Ph-MNP found. The incidence of Ph-MPN was 1.5 x 100.000 cases. The JAK2 V617F mutation study was performed in 96% of patients and only 30% had a bone marrow biopsy. Thrombotic events were observed in 29% of patients. Bleeding events were observed in 7%. Five-year overall survival was 87%.ConclusionsET is the most frequent Ph-MPN. The mean incidence was lower than reported in the literature, in part because of a sub diagnosis.

23 keywords...

hide…